Original ResearchNoncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
Key Words
Abbreviations and Acronyms
Cited by (0)
Drs. Piechnik and Robson have U.S. patents pending for: 61/387,591: SKP, MDR, Systems and Methods for Shortened Look Locker Inversion Recovery (ShMOLLI) Cardiac Gated Mapping of T1, September 29, 2010, all rights sold exclusively to Siemens Medical; and U.S. coexist patent pending 61/689,067: SKP, MDR, Color Map Design Method for Immediate Assessment of the Deviation From Established Normal Population Statistics and Its Application to Cardiovascular T1 Mapping Images. Drs. Karamitsos, Piechnik, Ferreira, Robson, Myerson, and Neubauer acknowledge support from the National Institute for Health Research, Oxford Biomedical Research Centre Programme. Dr. Banypersad is funded by an investigator-led research grant from GlaxoSmithKline. Dr. Ferreira is funded by the Alberta Innovates Health Solutions Clinical Fellowship and the University of Oxford Clarendon Fund Scholarship. Dr. Neubauer has a consultancy relationship with Novartis and has received support from the Oxford British Heart Foundation Centre of Research Excellence. Dr. Moon holds a grant from GlaxoSmithKline and is funded by the Higher Education Funding Council for England. University College London Hospital and University College London received a proportion of funding from the Department of Health NIHR Biomedical Research Centres funding scheme. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.